Jasper Therapeutics (JSPR) Misses Q3 EPS by 113c
Tweet
Share
E-mailGet Alerts JSPR Hot Sheet
Join SI Premium – FREE
Jasper Therapeutics (NASDAQ: JSPR) reported Q3 EPS of ($1.13).
For earnings history and earnings-related data on Jasper Therapeutics (JSPR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aggreko files for proposed IPO
- UL Solutions launches retail supply chain software platform
- Tetra Tech EC pays $57M to settle false soil test claims
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
